Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Total 13F shares
-
4,254,744
-
Share change
-
+2,911,555
-
Total reported value
-
$2,420,823
-
Put/Call ratio
-
245%
-
Price per share
-
$0.57
-
Number of holders
-
31
-
Value change
-
+$1,636,472
-
Number of buys
-
16
-
Number of sells
-
9
Institutional Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q2 2024
As of 30 Jun 2024,
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,254,744 shares.
The largest 10 holders included
Alyeska Investment Group, L.P., CVI Holdings, LLC, ENVESTNET ASSET MANAGEMENT INC, Values First Advisors, Inc., PVG ASSET MANAGEMENT CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Atria Investments, Inc, Atria Wealth Solutions, Inc., LPL Financial LLC, and Cetera Investment Advisers.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.